These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12636164)
1. Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients. Burkart GJ; Smaldone GC; Eldon MA; Venkataramanan R; Dauber J; Zeevi A; McCurry K; McKaveney TP; Corcoran TE; Griffith BP; Iacono AT Pharm Res; 2003 Feb; 20(2):252-6. PubMed ID: 12636164 [TBL] [Abstract][Full Text] [Related]
2. Lung deposition and pharmacokinetics of nebulized cyclosporine in lung transplant patients. Corcoran TE; Niven R; Verret W; Dilly S; Johnson BA J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):178-84. PubMed ID: 23668548 [TBL] [Abstract][Full Text] [Related]
3. Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Iacono AT; Smaldone GC; Keenan RJ; Diot P; Dauber JH; Zeevi A; Burckart GJ; Griffith BP Am J Respir Crit Care Med; 1997 May; 155(5):1690-8. PubMed ID: 9154878 [TBL] [Abstract][Full Text] [Related]
4. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study. Blot F; Tavakoli R; Sellam S; Epardeau B; Faurisson F; Bernard N; Becquemin MH; Frachon I; Stern M; Pocidalo JJ J Heart Lung Transplant; 1995; 14(6 Pt 1):1162-72. PubMed ID: 8719464 [TBL] [Abstract][Full Text] [Related]
5. Inhaled cyclosporine and pulmonary function in lung transplant recipients. Groves S; Galazka M; Johnson B; Corcoran T; Verceles A; Britt E; Todd N; Griffith B; Smaldone GC; Iacono A J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):31-9. PubMed ID: 19580368 [TBL] [Abstract][Full Text] [Related]
6. Delivery and distribution of aerosolized cyclosporine in lung allograft recipients. O'Riordan TG; Iacono A; Keenan RJ; Duncan SR; Burckart GJ; Griffith BP; Smaldone GC Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):516-21. PubMed ID: 7842214 [TBL] [Abstract][Full Text] [Related]
7. Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation. Behr J; Zimmermann G; Baumgartner R; Leuchte H; Neurohr C; Brand P; Herpich C; Sommerer K; Seitz J; Menges G; Tillmanns S; Keller M; J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):121-30. PubMed ID: 19422312 [TBL] [Abstract][Full Text] [Related]
8. Toward managing chronic rejection after lung transplant: the fate and effects of inhaled cyclosporine in a complex environment. Niven RW Adv Drug Deliv Rev; 2011; 63(1-2):88-109. PubMed ID: 20950661 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of a new pulmonary cyclosporine a powder formulation for prevention of transplant rejection in rats. Zijlstra GS; Wolting J; Prop J; Petersen AH; Hinrichs WL; Uges DR; Kerstjens HA; van der Bij W; Frijlink HW J Heart Lung Transplant; 2009 May; 28(5):486-92. PubMed ID: 19416778 [TBL] [Abstract][Full Text] [Related]
11. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose. Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression. Letsou GV; Safi HJ; Reardon MJ; Ergenoglu M; Li Z; Klonaris CN; Baldwin JC; Gilbert BE; Waldrep JC Ann Thorac Surg; 1999 Dec; 68(6):2044-8. PubMed ID: 10616974 [TBL] [Abstract][Full Text] [Related]
13. Nebulized cyclosporine in the rat: assessment of regional lung and extrapulmonary deposition. Blot F; Faurisson F; Bernard N; Sellam S; Friard S; Tavakoli R; Carbon C; Stern M; Bisson A; Pocidalo JJ; Caubarrere I Transplantation; 1999 Jul; 68(2):191-5. PubMed ID: 10440386 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients. Frauca E; Diaz MC; de la Vega A; Hierro L; Camarena C; Muñoz Bartolo G; Díez R; Murcia J; Gámez M; Sanchez Peinado C; López Santamaría M; Andrés I; Jara P Pediatr Transplant; 2007 Aug; 11(5):530-5. PubMed ID: 17631022 [TBL] [Abstract][Full Text] [Related]
15. Preservation of post-transplant lung function with aerosol cyclosporin. Corcoran TE; Smaldone GC; Dauber JH; Smith DA; McCurry KR; Burckart GJ; Zeevi A; Griffith BP; Iacono AT Eur Respir J; 2004 Mar; 23(3):378-83. PubMed ID: 15065825 [TBL] [Abstract][Full Text] [Related]
17. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation. Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903 [TBL] [Abstract][Full Text] [Related]
18. Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection. Kahan BD; Welsh M; Schoenberg L; Rutzky LP; Katz SM; Urbauer DL; Van Buren CT Transplantation; 1996 Sep; 62(5):599-606. PubMed ID: 8830822 [TBL] [Abstract][Full Text] [Related]
19. Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation. Keenan RJ; Duncan AJ; Yousem SA; Zenati M; Schaper M; Dowling RD; Alarie Y; Burckart GJ; Griffith BP Transplantation; 1992 Jan; 53(1):20-5. PubMed ID: 1733067 [TBL] [Abstract][Full Text] [Related]
20. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation. Canadian Neoral Renal Transplantation Study Group Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]